ESC 2026: Statins show worth despite emergence of PCSK9 inhibitors - Pharmaceutical Technology

The Australia-based STAREE trial is the first of its kind demonstrating the preventative effects of statins in older patients. The Australia-based STAREE trial is the first of its kind demonstrating the preventative effects of statins in older patients. Data from the Australia-based study, called STAREE, was presented in a hot line session at the European Society of Cardiology (ESC) Congress in Munich, Germany. Credit: PeopleImages/Shutterstock.com. A type of statin significantly reduces the risk of major cardiovascular events in elderly patients, demonstrating their continued importance despite the rising use of PCSK9 inhibitors in the past decade. Atorvastatin, a generic medicine but…

Source: Pharmaceutical Technology